Skip to main content
Clinical Trials/NCT05408468
NCT05408468
Completed
Not Applicable

Pilot Evaluation of FAMCOPE-ICU

University Hospitals Cleveland Medical Center2 sites in 1 country49 target enrollmentAugust 15, 2022

Overview

Phase
Not Applicable
Intervention
FAMCOPE-ICU
Conditions
Emotion Regulation
Sponsor
University Hospitals Cleveland Medical Center
Enrollment
49
Locations
2
Primary Endpoint
Acceptability of Intervention Measure
Status
Completed
Last Updated
9 days ago

Overview

Brief Summary

Having a family member or loved one in the ICU can be a very stressful experience. The investigators have created a tablet-based tool (FAMCOPE-ICU) that is designed to help people in this position cope with this experience.

Registry
clinicaltrials.gov
Start Date
August 15, 2022
End Date
July 27, 2023
Last Updated
9 days ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor
Principal Investigator

Grant Pignatiello

Instructor and NCATS Clinical Research KL2 Scholar

University Hospitals Cleveland Medical Center

Eligibility Criteria

Inclusion Criteria

  • Patient Inclusion Criteria:
  • 18-89 years old
  • Intensive Care Unit (ICU) length of stay (LOS) \>= 48 hours
  • No anticipated ICU LOS for next 24 hours
  • Unable to make healthcare decisions
  • Family Inclusion Criteria
  • Identified by critical care team as legally authorized representative (LAR)
  • Able to speak or comprehend English
  • \>= 18 years old

Exclusion Criteria

  • Less than 18 years or older than 89 years
  • ICU LOS \< 48 hours
  • Anticipated ICU discharge within next 24 hours
  • Able to make healthcare decisions
  • Family Exclusion Criteria
  • Not identified by critical care team as the LAR
  • Unable to speak or comprehend English
  • \< 18 years old

Arms & Interventions

FAMCOPE-ICU

A digital eHealth emotion regulation and coping intervention.

Intervention: FAMCOPE-ICU

Usual Care

The care and support routinely provided to SDMs of critically ill patients.

Outcomes

Primary Outcomes

Acceptability of Intervention Measure

Time Frame: After dose 3, 5 minutes

Four item self-report survey; item responses range from 1 (completely disagree) to 5 (completely agree)

Acceptability of Intervention Measure

Time Frame: After dose 1, 5 minutes

Four item self-report survey; item responses range from 1 (completely disagree) to 5 (completely agree)

Acceptability of Intervention Measure

Time Frame: After dose 2, 5 minutes

Four item self-report survey; item responses range from 1 (completely disagree) to 5 (completely agree)

Secondary Outcomes

  • Change in Anxiety as Measured by PROMIS Anxiety Short Form(Baseline (enrollment), one week.)
  • Change in Depression as Measured by PROMIS Depression Short Form(Baseline (enrollment), one week.)
  • Sleep Disturbance as Measured by PROMIS Sleep Disturbance Short Form(Baseline (enrollment))
  • Decision Fatigue Scale(One week post-enrollment)
  • Decisional Conflict Scale(One week post-enrollment)
  • Satisfaction as Measured by the Family Satisfaction in the Intensive Care Unit Scale - 24R(One week post-enrollment)

Study Sites (2)

Loading locations...

Similar Trials